Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Sullivan

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Journal of Cardiovascular Pharmacology|May 17, 2000
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbitsD R Abendschein, P K Baum, D J Martin, et al.
Journal of Medicinal Chemistry|April 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compoundsR Lis, T K Morgan, R J DeVita, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 9, 2000
Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient miceY X Wang, M Halks-Miller, R Vergona, et al.
European Journal of Pharmacology|December 13, 2001
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosisT B McClanahan, G W Hicks, A L Morrison, et al.
Journal of Medicinal Chemistry|December 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2R Lis, D D Davey, T K Morgan, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and class III antiarrhythmic activity of (phenylbut-2-enyl)ammonium salts. Effect of conformation on activityT K Morgan, R A Wohl, W C Lumma, et al.
The American Journal of Pathology|October 5, 2001
Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient miceY X Wang, B Martin-McNulty, A D Freay, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2000
Hemodynamic changes in apolipoprotein E-knockout miceC J Hartley, A K Reddy, S Madala, et al.
Plos One|July 21, 2012
Making robust policy decisions using global biodiversity indicatorsEmily Nicholson, Ben Collen, Alberto Barausse, et al.
Journal of Medicinal Chemistry|September 11, 1998
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor XaG B Phillips, B O Buckman, D D Davey, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Cardiovascular Pharmacology|May 17, 2000
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbitsD R Abendschein, P K Baum, D J Martin, et al.
Journal of Medicinal Chemistry|April 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compoundsR Lis, T K Morgan, R J DeVita, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 9, 2000
Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient miceY X Wang, M Halks-Miller, R Vergona, et al.
European Journal of Pharmacology|December 13, 2001
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosisT B McClanahan, G W Hicks, A L Morrison, et al.
Journal of Medicinal Chemistry|December 1, 1987
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2R Lis, D D Davey, T K Morgan, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and class III antiarrhythmic activity of (phenylbut-2-enyl)ammonium salts. Effect of conformation on activityT K Morgan, R A Wohl, W C Lumma, et al.
The American Journal of Pathology|October 5, 2001
Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient miceY X Wang, B Martin-McNulty, A D Freay, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2000
Hemodynamic changes in apolipoprotein E-knockout miceC J Hartley, A K Reddy, S Madala, et al.
Plos One|July 21, 2012
Making robust policy decisions using global biodiversity indicatorsEmily Nicholson, Ben Collen, Alberto Barausse, et al.
Journal of Medicinal Chemistry|September 11, 1998
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor XaG B Phillips, B O Buckman, D D Davey, et al.
Pageof 8